Masimo Corporation (MASI)
NASDAQ: MASI · IEX Real-Time Price · USD
137.00
+0.75 (0.55%)
May 3, 2024, 4:00 PM EDT - Market closed
Masimo Employees
Masimo had 3,800 employees on December 31, 2023. The number of employees decreased by 200 or -5.00% compared to the previous year.
Employees
3,800
Change (1Y)
-200
Growth (1Y)
-5.00%
Revenue / Employee
$538,974
Profits / Employee
$21,447
Market Cap
7.25B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3,800 | -200 | -5.00% |
Dec 31, 2022 | 4,000 | 1,800 | 81.82% |
Dec 31, 2021 | 2,200 | 200 | 10.00% |
Dec 31, 2020 | 2,000 | 400 | 25.00% |
Dec 28, 2019 | 1,600 | 100 | 6.67% |
Dec 29, 2018 | 1,500 | 100 | 7.14% |
Dec 30, 2017 | 1,400 | 157 | 12.63% |
Dec 31, 2016 | 1,243 | -57 | -4.38% |
Dec 31, 2015 | 1,300 | 100 | 8.33% |
Dec 31, 2014 | 1,200 | -1,939 | -61.77% |
Dec 28, 2013 | 3,139 | 273 | 9.53% |
Dec 29, 2012 | 2,866 | 318 | 12.48% |
Jan 1, 2011 | 2,548 | 151 | 6.30% |
Dec 31, 2009 | 2,397 | 198 | 9.00% |
Dec 31, 2009 | 2,199 | 460 | 26.45% |
Dec 31, 2008 | 1,739 | 391 | 29.01% |
Dec 29, 2007 | 1,348 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Bio-Rad Laboratories | 8,030 |
Bio-Rad Laboratories | 8,030 |
Globus Medical | 5,000 |
Jazz Pharmaceuticals | 2,800 |
Inspire Medical Systems | 1,011 |
Ascendis Pharma | 879 |
Cytokinetics | 423 |
Revolution Medicines | 378 |
MASI News
- 4 days ago - Masimo's billionaire CEO put shares on margin to get cash while keeping ownership ahead of proxy fight - CNBC
- 12 days ago - Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7 - Business Wire
- 19 days ago - Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile - Business Wire
- 25 days ago - Masimo To Explore Spin-Off Of Its Consumer Unit - Forbes
- 4 weeks ago - Masimo Responds to Politan Capital's Nomination of Director Candidates and Refutes Politan's False Claims - Business Wire
- 5 weeks ago - Masimo May Look at Joint Venture for Consumer Split, CEO Says - WSJ
- 5 weeks ago - Activist investor plans second fight at Masimo, sending shares up 12% - CNBC
- 5 weeks ago - Politan Nominates Two Independent Candidates for Masimo Board - Business Wire